Pilot study to investigate differences in middle molecules, oxidative stress and markers of peripheral vascular disease in patients treated by high flux haemodialysis and haemodiafiltration
Fig 2
Ischaemia modified albumin ratio (IMAR) in patients treated by high-flux haemodialysis (HD) and haemodiafiltration (HDF).
Red triangular symbols represent mean for treatment group (P = 0.035) and the horizontal black line represents the median for treatment group (P = 0.013).